PRISMASOL BO SOLUTION [SIN11635P]
Active ingredients: CALCIUM CHLORIDE DIHYDRATE | MAGNESIUM CHLORIDE HEXAHYDRATE | SODIUM CHLORIDE | SODIUM HYDROGEN CARBONATE | SODIUM LACTATE
Last updated on 9 October 2026
Product Info
PRISMASOL BO SOLUTION
[SIN11635P]
Product information
Active Ingredient and Strength | CALCIUM CHLORIDE DIHYDRATE - 0.257 G/L |
Dosage Form | SOLUTION |
Manufacturer and Country | BIEFFE MEDITAL S.P.A - ITALY |
Registration Number | SIN11635P |
Licence Holder | VANTIVE PTE. LTD. |
Forensic Classification | GENERAL SALE LIST |
Anatomical Therapeutic Chemical (ATC) code | B05ZB |
Prescription-only Medicines with Exemptions for Supply without Prescription | NA |
Indication
2. WHAT IS PRISMASOL B0 AND WHAT IS IT USED FOR?
PRISMASOL B0 is a solution for haemofiltration, haemodiafiltration and continuous haemodialysis. The processes of haemofiltration and continuous haemodialysis aim at normalising the composition of the blood.
PRISMASOL B0 is a solution packed in a two compartment bag. The electrolyte solution (in the small compartment A) must be mixed with the buffer solution (in the large compartment B) before use to obtain the final solution suitable for the treatment.
PRISMASOL B0 is used in the treatment of acute kidney disease (renal failure), as substitution solution in continuous haemofiltration and haemodiafiltration and as dialysis solution in continuous haemodialysis. PRISMASOL B0 may also be used in case of drug poisoning with dialysable or filterable substances.
PRISMASOL B0 is particularly indicated when you are suffering from high potassium level in your blood (hyperkalaemic).
Dosing
4. HOW SHOULD YOU USE PRISMASOL B0?
PRISMASOL B0 is to be used only by or under the direction of a physician competent in intensive care treatment using haemofiltration, haemodiafiltration and haemodialysis.
The volume of Prismasol B0, and therefore the dose used, will depend on your condition. The dose volume will be determined by the physician responsible for your treatment.
Prismasol B0 can be administered directly into the bloodstream (intravenously) or via haemodialysis, where the solution flows on one side of a dialysis membrane while the blood flows on the other side.
Aseptic technique should be used throughout the handling and administration to the patient.
PRISMASOL B0 should be used only if the solution is clear, the overwrap is not damaged, peel seal is not broken and all seals intact.
The large compartment B is fitted with an injection port for the possible addition of other necessary drugs after reconstitution of the solution. It is the responsibility of the physician to judge the compatibility of an additive medication with Prismasol B0 by checking for eventual colour change and/or eventual precipitation, insoluble complexes or crystals. Before adding a medication, verify it is soluble and stable in water within the pH limits of Prismasol B0 (pH limits of reconstituted solution is 7.0 to 8.5). Additives may be incompatible. The Instructions for Use of the medication to be added must be consulted.
Remove any fluid from the injection port, hold the bag upside down, insert the drug through the injection port and mix thoroughly. The solution must be administered immediately. The introduction and mixing of additives must always be performed prior to connecting the solution bag to the extracorporeal circuit.
Contraindications
3. BEFORE YOU USE PRISMASOL B0
The instructions for use should carefully be followed.
Do not use Prismasol B0 if you are allergic to one of the active substances or any of the other ingredients.